Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
mi
from
Concord, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
mi
from
Concord, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Center for Cancer Care at Exeter Hospital
mi
from
Exeter, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Center for Cancer Care at Exeter Hospital
mi
from
Exeter, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
New Hampshire Oncology - Hematology, PA - Hooksett
mi
from
Hooksett, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
New Hampshire Oncology - Hematology, PA - Hooksett
mi
from
Hooksett, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Lakes Region General Hospital
mi
from
Laconia, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Lakes Region General Hospital
mi
from
Laconia, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Norris Cotton Cancer Center at Catholic Medical Center
mi
from
Manchester, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Norris Cotton Cancer Center at Catholic Medical Center
mi
from
Manchester, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Elliot Regional Cancer Center at Elliot Hospital
mi
from
Manchester, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Elliot Regional Cancer Center at Elliot Hospital
mi
from
Manchester, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Foundation Medical Partners
mi
from
Nashua, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Foundation Medical Partners
mi
from
Nashua, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Oncology Center at St. Joseph Hospital
mi
from
Nashua, NH
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Oncology Center at St. Joseph Hospital
mi
from
Nashua, NH
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
St. Barnabas Medical Center Cancer Center
mi
from
Livingston, NJ
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
St. Barnabas Medical Center Cancer Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Lipson Cancer and Blood Center at Rochester General Hospital
mi
from
Rochester, NY
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Lipson Cancer and Blood Center at Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Cape Fear Valley Medical Center Cancer Center
mi
from
Fayetteville, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Cape Fear Valley Medical Center Cancer Center
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Maria Parham Medical Center
mi
from
Henderson, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Maria Parham Medical Center
mi
from
Henderson, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Southeastern Regional Medical Center
mi
from
Lumberton, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Southeastern Regional Medical Center
mi
from
Lumberton, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Granville Medical Center
mi
from
Oxford, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Granville Medical Center
mi
from
Oxford, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
mi
from
Pinehurst, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Duke Health Raleigh Hospital
mi
from
Raleigh, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Duke Health Raleigh Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Person Memorial Hospital
mi
from
Roxboro, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Person Memorial Hospital
mi
from
Roxboro, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Marion L. Shepard Cancer Center at Beaufort County Hospital
mi
from
Washington, NC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Marion L. Shepard Cancer Center at Beaufort County Hospital
mi
from
Washington, NC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Keyserling Cancer Center at Beaufort Memorial Hospital
mi
from
Beaufort, SC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Keyserling Cancer Center at Beaufort Memorial Hospital
mi
from
Beaufort, SC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Coastal Cancer Center - Myrtle Beach
mi
from
Myrtle Beach, SC
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Coastal Cancer Center - Myrtle Beach
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Fletcher Allen Health Care - University Health Center Campus
mi
from
Burlington, VT
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Fletcher Allen Health Care - University Health Center Campus
mi
from
Burlington, VT
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Medical Oncology and Hematology Associates of North Virginia - Fairfax
mi
from
Fairfax, VA
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Medical Oncology and Hematology Associates of North Virginia - Fairfax
mi
from
Fairfax, VA
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
St. Mary's Regional Cancer Center at St. Mary's Medical Center
mi
from
Huntington, WV
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
St. Mary's Regional Cancer Center at St. Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Washington Cancer Institute at Washington Hospital Center
mi
from
Washington, D.C.,
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Washington Cancer Institute at Washington Hospital Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Walter Reed Army Medical Center
mi
from
Washington, D.C.,
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Walter Reed Army Medical Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated:  8/7/2017
Mountainview Medical
mi
from
Berlin Corners, VT
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Status: Enrolling
Updated: 8/7/2017
Mountainview Medical
mi
from
Berlin Corners, VT
Click here to add this to my saved trials
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Breast Cancer Prevention Using Synergistic Prostaglandin Inhibitors (The Vitamin D/Celecoxib Study)
Status: Enrolling
Updated:  8/8/2017
University of North Dakota
mi
from
Grand Forks, ND
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Breast Cancer Prevention Using Synergistic Prostaglandin Inhibitors (The Vitamin D/Celecoxib Study)
Status: Enrolling
Updated: 8/8/2017
University of North Dakota
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Changes in Biomarkers Using Prostaglandin Inhibitors
Prostaglandin Inhibition to Prevent Breast Cancer
Status: Enrolling
Updated:  8/8/2017
University of North Dakota
mi
from
Grand Forks, ND
Changes in Biomarkers Using Prostaglandin Inhibitors
Prostaglandin Inhibition to Prevent Breast Cancer
Status: Enrolling
Updated: 8/8/2017
University of North Dakota
mi
from
Grand Forks, ND
Click here to add this to my saved trials
CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer
A Phase IB Study of Crizotinib (XALKORI) and Sunitinib (SUTENT) in Metastatic Breast Cancer
Status: Enrolling
Updated:  8/8/2017
Lester and Sue Smith Breast Center at Baylor College of Medicine
mi
from
Houston, TX
CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer
A Phase IB Study of Crizotinib (XALKORI) and Sunitinib (SUTENT) in Metastatic Breast Cancer
Status: Enrolling
Updated: 8/8/2017
Lester and Sue Smith Breast Center at Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer
An Open-Label Combination Study of Capecitabine and Standard Paclitaxel Therapy as First or Second Line Therapy in Women With Metastatic Breast Carcinoma
Status: Enrolling
Updated:  8/15/2017
PPD Development
mi
from
Wilmington, NC
Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer
An Open-Label Combination Study of Capecitabine and Standard Paclitaxel Therapy as First or Second Line Therapy in Women With Metastatic Breast Carcinoma
Status: Enrolling
Updated: 8/15/2017
PPD Development
mi
from
Wilmington, NC
Click here to add this to my saved trials
Acupuncture for Chronic Lymphedema
Acupuncture for Chronic Lymphedema: A Randomized Wait-list Controlled Trial
Status: Enrolling
Updated:  8/21/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Acupuncture for Chronic Lymphedema
Acupuncture for Chronic Lymphedema: A Randomized Wait-list Controlled Trial
Status: Enrolling
Updated: 8/21/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Status: Enrolling
Updated:  8/24/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Status: Enrolling
Updated: 8/24/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated:  8/24/2017
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated: 8/24/2017
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated:  8/24/2017
M D Anderson Cancer Center
mi
from
Houston, TX
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated: 8/24/2017
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated:  8/24/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Phase Ib Dose Escalation and Biomarker Study of MK-2206 in Combination With Standard Doses of Weekly Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in Advanced Breast Cancer
Status: Enrolling
Updated: 8/24/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated:  8/24/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated: 8/24/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated:  8/24/2017
Clinical Research Facility
mi
from
Fort Myers, FL
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated: 8/24/2017
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated:  8/24/2017
Clinical Research Facility
mi
from
Miami, FL
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated: 8/24/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated:  8/24/2017
Clinical Research Facility
mi
from
Boston, MA
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
A Phase III, Randomized, Open Label, Multicenter, Controlled Trial of Niraparib Versus Physician's Choice in Previously-treated, HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
Status: Enrolling
Updated: 8/24/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials